EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion by suppressing CXCL10 and CD8+ T cell activation

Xinchun Zhang, Jinjiang Xue, Cunyan Zhao, Chenqiuyue Zeng, Jiacheng Zhong, Gangfeng Yu, Xi Yang, Yao Ling, Dazhen Li, Jiaxiao Yang, Yun Xiu, Hongda Li und 7 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci195556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Xinchun Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Chemokine CXCL10, Glioblastoma, CD8-Positive T-Lymphocytes, Oligodendrocyte Transcription Factor 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Scientific and Technological Research Program of Chongqing Municipal Education Commission, Natural Science Foundation of Chongqing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CXCL10GlioblastomaCD8-Positive T-LymphocytesOligodendrocyte Transcription Factor 2Brain NeoplasmsNeoplasm ProteinsLymphocyte ActivationTumor EscapeAnimalsHumansMiceHistone DeacetylasesMice, KnockoutCell Line, TumorFemaleSTAT3 Transcription Factor

Stichwörter der Autor:innen

Brain cancerCell biologyImmunologyOncology

Substanzen

Chemokine CXCL10Oligodendrocyte Transcription Factor 2CXCL10 protein, humanCxcl10 protein, mouseNeoplasm ProteinsHistone DeacetylasesSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Neurosurgery, Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.
  • Chongqing University Central Hospital, Chongqing, China.
  • College of Pharmacy, Chongqing Medical University, Chongqing, China.
  • Department of Pediatrics, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Förderung

  • National Natural Science Foundation of China
  • Scientific and Technological Research Program of Chongqing Municipal Education Commission
  • Natural Science Foundation of Chongqing
  • CQMU Program for Youth Innovation in Future Medicine

Zitieren

APA

Zhang, X., Xue, J., Zhao, C., Zeng, C., Zhong, J., Yu, G., Yang, X., Ling, Y., Li, D., Yang, J., Xiu, Y., Li, H., Hong, S., Qiao, L., Chen, S., Lu, Q. R., Deng, Y., Tang, Z., & Lu, F. (2026). Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion by suppressing CXCL10 and CD8+ T cell activation. Journal of Clinical Investigation. https://doi.org/10.1172/jci195556

Vancouver

Zhang X, Xue J, Zhao C, Zeng C, Zhong J, Yu G, et al. Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion by suppressing CXCL10 and CD8+ T cell activation. Journal of Clinical Investigation. 2026. doi:10.1172/jci195556

BibTeX
@article{Zhang2026,
  author = {Zhang, Xinchun and Xue, Jinjiang and Zhao, Cunyan and Zeng, Chenqiuyue and Zhong, Jiacheng and Yu, Gangfeng and Yang, Xi and Ling, Yao and Li, Dazhen and Yang, Jiaxiao and Xiu, Yun and Li, Hongda and Hong, Shiyuan and Qiao, Liangjun and Chen, Song and Lu, Q Richard and Deng, Yaqi and Tang, Zhaohua and Lu, Fanghui},
  title = {Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion by suppressing CXCL10 and CD8+ T cell activation},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci195556}
}
Kostenlos starten →